Molecular Genetics of Alzheimer's Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, which affects up to 50% of individuals above the age of 85. Due to the global increase in the aging population, early diagnosis and treatment of AD are becoming increasingly important, not only from a human point of view, but also from an economic perspective. Thus, identification of the novel AD-related target genes and the subsequent mechanistic characterization of these targets are essential for the development of new therapeutic approaches and antecedent biomarkers.

Group Leader

Curriculum Vitae

Mikko Hiltunen, PhD, Professor of Tissue and Cell Biology
mikko.hiltunen (at) uef.fi